FDA approves CardioGenesis' Intraoperative TransMyocardial Revascularisation (ITMR) system trials:
This article was originally published in Clinica
Executive Summary
The US FDA has approved the expansion of Phase II clinical trials for CardioGenesis' Intraoperative TransMyocardial Revascularisation system (see Clinica No 706, p 13).